Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesFatty acids as metabolic mediators in innate immunity
European Journal of Clinical Investigation, 07/02/09
Kopp A et al. - Monocytic activation is differentially regulated by fatty acids and depends on triglyceride levels in T2D. The main finding of the present study shows that eicosapentaenoic acid inhibits the specific binding of LPS to TLR4/MD-2. Eicosapentaenoic acid represents a new anti-inflammatory LPS-antagonist.
Today in Endocrine...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment with the PPAR-gamma agonist rosiglitazone down-regulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
European Journal of Endocrinology, 11/24/09
Autoimmune Polyglandular Syndrome Type 2 With Myasthenia Gravis Crisis
The Neurologist, 11/20/09
Diabetes associated with autoimmune pancreatitis: new insights into the mechanism of beta-cell dysfunction
Expert Review of Endocrinology & Metabolism, 11/17/09
Sponsor
Article Search
Sponsor